US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 8.320
  • -0.070-0.83%
Close Apr 28 16:00 ET
  • 8.010
  • -0.310-3.73%
Pre 04:14 ET
1.74BMarket Cap-19.35P/E (TTM)

About BioCryst Pharmaceuticals Company

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Company Profile

SymbolBCRX
Company NameBioCryst Pharmaceuticals
Listing DateMar 3, 1994
Issue Price6.50
Founded1986
CEOMr. Jon P. Stonehouse
MarketNASDAQ
Employees580
Fiscal Year Ends12-31
Address4505 Emperor Boulevard,Suite 200
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27703-8457
Phone1-919-859-1302
Websitehttp://www.biocryst.com

Company Executives

  • Name
  • Position
  • Salary
  • Jon P. Stonehouse
  • Director, President, Chief Executive Officer, Interim Chief Financial Officer and Interim Principal Accounting Officer
  • 8.32M
  • Alane P. Barnes
  • Chief Legal Officer and Corporate Secretary
  • 3.24M
  • Charles K. Gayer
  • Chief Commercial Officer
  • 3.38M
  • Dr. Helen M. Thackray, M.D.
  • Chief Research and Development Officer
  • 3.57M
  • Dr. Nancy J. Hutson, PhD
  • Chairman of the Board
  • 377.97K
  • Theresa M. Heggie
  • Independent Director
  • 342.97K
  • A. Machelle Sanders
  • Independent Director
  • 330.47K
  • Vincent J. Milano
  • Independent Director
  • 347.97K
  • Stephen J. Aselage
  • Independent Director
  • 346.72K
  • George B. Abercrombie
  • Independent Director
  • 337.97K
  • Alan G. Levin
  • Independent Director
  • 342.97K
  • Dr. Steven K. Galson, M.D.
  • Independent Director
  • 330.47K
  • Dr. Amy E. McKee, M.D.
  • Independent Director
  • 335.47K

Market Insights

Inverse ETF Inverse ETF
No. Symbol Turnover
Sample Name
Sample Code
 3.29B
Sample Name
Sample Code
 1.22B
Sample Name
Sample Code
 785.32M
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
526.02M
5
T-Rex 2x Inverse Tesla Daily Target ETF
TSLZ
314.56M
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 140.140
Sample Name
Sample Code
 9.600
Sample Name
Sample Code
 101.120
4
D.R. Horton
DHI
125.170
5
Lennar Corp
LEN
108.150
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 140.140
Sample Name
Sample Code
 1110.380
Sample Name
Sample Code
 549.740
4
Apple
AAPL
210.140
5
Tesla
TSLA
285.880
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.7150
Sample Name
Sample Code
 2.010
Sample Name
Sample Code
 0.1600
4
Argo Blockchain
ARBK
0.4050
5
Bit Digital
BTBT
2.110
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Earnings Season Underway

Earnings season is here. What to know?

- No more -